Hovis (MILV CEO) could be talking to Mathias
(second largest shareholder, and co-founder of the mega billion dollar Carlyl group),
head of the Trust fund that controls the UPennMed patents
and Dr. Fountain about dragging out some promising related tech off the shelf of the UPennMed Patents (must 50,000+ of them to drool over) from prior what if work on Corona-virus vacines, and NIH/CDC about a rush US Gov grant to rush test a UPennMed prior research project for use in immediate trials for COVID19.
We would not know till the PR dropped and the stock price gaped up in minutes to a dime before folks figured out what was going on.
No time to be on the MILV fence with all these folks on the Same #NFL Super Bowl Pharmaceutical Biotech birth team as Larry Kubin and Michael Fountain, and Dr Coven, and possibly Dr. Dorsey at UpennMed.
I think I just talked my self into buying another million $MILV shares.
News 
Market Data 
Discover 
